Cargando…
Staging Alzheimer’s Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers
This study aims to develop a composite biomarker that can accurately measure the sequential biological stages of Alzheimer’s disease (AD) on an individual level. We selected 144 subjects from the Alzheimer’s Disease Neuroimaging Initiative 2 datasets. Ten biomarkers, from brain function and structur...
Autores principales: | Chen, Guangyu, Shu, Hao, Chen, Gang, Ward, B. Douglas, Antuono, Piero G., Zhang, Zhijun, Li, Shi-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055443/ https://www.ncbi.nlm.nih.gov/pubmed/27567874 http://dx.doi.org/10.3233/JAD-160537 |
Ejemplares similares
-
Lights and Shadows of Cerebrospinal Fluid Biomarkers in the Current Alzheimer’s Disease Framework
por: Gallucci, Maurizio, et al.
Publicado: (2022) -
Predicting progression from mild cognitive impairment to Alzheimer’s disease on an individual subject basis by applying the CARE index across different independent cohorts
por: Chen, Jiu, et al.
Publicado: (2019) -
Spicy food consumption is associated with cognition and cerebrospinal fluid biomarkers of Alzheimer disease
por: Tian, Ding-Yuan, et al.
Publicado: (2021) -
Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
por: Perrin, Richard J., et al.
Publicado: (2011) -
Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Their Role in Clinical Chemistry
por: Blennow, Kaj, et al.
Publicado: (2000)